Abstract
Selective cyclooxygenase 2 (COX-2) inhibitors are known to affect renal prostaglandins (epoprostenol and dinoprostone), which are at least in part COX-2 dependent. Consequently, adverse events including hypertension, peripheral edema, hypercalemia, hyponatremia, and acute renal failure have been reported to occur with the new COX-2-specific inhibitors. This case report posits celecoxib as a likely cause of renal papillary necrosis and alerts physicians to the possibility of this additional renal complication with COX-2-specific inhibitors.
MeSH terms
-
Arthritis, Rheumatoid / drug therapy
-
Celecoxib
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / administration & dosage
-
Cyclooxygenase Inhibitors / adverse effects*
-
Female
-
Humans
-
Isoenzymes / antagonists & inhibitors*
-
Kidney Papillary Necrosis / chemically induced*
-
Kidney Papillary Necrosis / diagnostic imaging
-
Kidney Papillary Necrosis / enzymology
-
Membrane Proteins
-
Middle Aged
-
Prostaglandin-Endoperoxide Synthases
-
Pyrazoles
-
Sulfonamides / administration & dosage
-
Sulfonamides / adverse effects*
-
Urography
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Membrane Proteins
-
Pyrazoles
-
Sulfonamides
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Celecoxib